David D. Chang
President and CEO at Allogene Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Allogene Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Allogene Therapeutics Inc. June 18, 202597.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Allogene Therapeutics Inc. | Open-market sale | −47,763 | $2.47 | $117,975 |
| Feb 2, 2026 | Allogene Therapeutics Inc. | Open-market sale | −95,269 | $1.80 | $171,484 |
| Mar 14, 2025 | Allogene Therapeutics Inc. | Open-market sale | −46,668 | $1.96 | $91,469 |
| Feb 3, 2025 | Allogene Therapeutics Inc. | Open-market sale | −46,003 | $1.68 | $77,285 |
| Jan 24, 2025 | Allogene Therapeutics Inc. | Grant or award | +552,174 | — | — |
| May 16, 2024 | Allogene Therapeutics Inc. | Grant or award | +344,828 | $2.90 | $1,000,001 |
| Mar 14, 2024 | Allogene Therapeutics Inc. | Shares withheld for tax | −53,393 | $4.33 | $231,192 |
| Jan 25, 2024 | Allogene Therapeutics Inc. | Grant or award | +317,800 | — | — |
| Mar 22, 2023 | Allogene Therapeutics Inc. | Grant or award | +1,924,464 | — | — |
| Mar 14, 2023 | Allogene Therapeutics Inc. | Shares withheld for tax | −22,340 | $5.56 | $124,210 |
Questions about David D. Chang
What boards is David D. Chang on?
David D. Chang sits on the board of Allogene Therapeutics Inc.
What company is David D. Chang the CEO of?
David D. Chang is President and CEO of Allogene Therapeutics Inc.
How long has David D. Chang served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.